Skip to main content
OpenTrials

Clinical trial condition

Measles; Mumps; Rubella

Explore clinical trials studying Measles; Mumps; Rubella. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Measles; Mumps; Rubella trial results

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

NCT02184572

Conditions
Infections, Measles, Measles-Mumps-Rubella Vaccine, +16 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
View all 95 locations
View Trial Details

Related conditions